GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $54,000 | +3.8% | 1,239 | +4.8% | 0.01% | +14.3% |
| Q1 2022 | $52,000 | -7.1% | 1,182 | -6.9% | 0.01% | 0.0% |
| Q4 2021 | $56,000 | +75.0% | 1,269 | +51.8% | 0.01% | +75.0% |
| Q3 2021 | $32,000 | +100.0% | 836 | +104.4% | 0.00% | +100.0% |
| Q2 2021 | $16,000 | +6.7% | 409 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $15,000 | 0.0% | 409 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | 0.0% | 409 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $15,000 | -11.8% | 409 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $17,000 | +6.2% | 409 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | -15.8% | 409 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $19,000 | +280.0% | 409 | +235.2% | 0.00% | +300.0% |
| Q3 2019 | $5,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $5,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $5,000 | -54.5% | 122 | -58.6% | 0.00% | -50.0% |
| Q4 2018 | $11,000 | +120.0% | 295 | +136.0% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | -61.5% | 125 | -61.8% | 0.00% | -33.3% |
| Q2 2018 | $13,000 | 0.0% | 327 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $13,000 | +225.0% | 324 | +165.6% | 0.00% | +200.0% |
| Q4 2017 | $4,000 | -20.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $5,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | -98.1% | 122 | -98.0% | 0.00% | -97.4% |
| Q3 2016 | $257,000 | +2470.0% | 5,970 | +2397.9% | 0.04% | +1166.7% |
| Q2 2016 | $10,000 | 0.0% | 239 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $10,000 | 0.0% | 239 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $10,000 | +100.0% | 239 | +95.9% | 0.00% | +100.0% |
| Q3 2015 | $5,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $5,000 | -16.7% | 122 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | +20.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $5,000 | -16.7% | 122 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $6,000 | -14.3% | 122 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $7,000 | 0.0% | 122 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $7,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $7,000 | +16.7% | 122 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $6,000 | 0.0% | 122 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $6,000 | – | 122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |